Celebrex, Naproxen Won’t Prevent Mental Decline (HealthDay) Posted on May 13th
For the new study, 2,117 men and women over the age of 70 with a family
history of Alzheimer’s disease were randomly assigned to receive 200
milligrams of Celebrex twice a day, 220 milligrams of naproxen twice a
day, or a placebo. Participants did not have a diagnosis of Alzheimer’s,
other dementias or mild cognitive impairment at the March 2001, start of
the trial.